MMED MiniMed Group, Inc.
Company Analysis
Latest News
🟢 MMED extends move to 5.0% up
MMED is trading at $14.96, up 5.0% versus the comparison close of $14.24 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MMED is trading 4.3% up today after appointing new directors to its Board
• MindMed (MMED) announced the appointment of David Endicott and Linnea Burman to its Board of Directors, effective June 29, 2026, expanding the Board from...
🟢 MMED is trading 4.4% up today amid broad market rotation and growth sector volatility
MMED is trading at $14.75 (+4.39%) as of June 25, 2026, amid broad market rotation and ongoing volatility in growth and healthcare stocks rather than a...
🟢 MMED extends move to 6.3% up
MMED is trading at $14.61, up 6.3% versus the comparison close of $13.74 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MMED is trading 4.5% up today on positive Phase 3 results for LSD-based depression therapy DT120
MMED is trading 4.5% up today at $14.36 after investors reacted to highly positive Phase 3 results for its LSD-based depression therapy, DT120. • The company...
🟢 MMED is trading 13% up today after its LSD-based therapy showed "profound" efficacy in Phase 3 depression trial
MindMed (MMED) is trading 13% up at $15.53 in pre-market, driven by positive developments in its clinical pipeline. • The company, formerly known as Definium,...
🔴 MiniMed Group, Inc. is trading 4.4% down today as it gives back gains following its recent insulin pump launch
MiniMed Group, Inc. is trading at $14.12 (4.4%**) down in pre-market, giving back a portion of last week’s gains after a stretch of choppy trading. * The move...
MiniMed Launches MiniMed Flex, Its Smallest App-Controlled Insulin Pump
MiniMed launched the MiniMed Flex system in the U.S. as its smallest insulin pump to date. Users control the screenless device entirely through a smartphone...